Comment Re:Newlink's license invalid? (Score 2) 70
It would seem from http://www.cbc.ca/thecurrent/e... last week's coverage that Newlink had already violated the terms of their license.
How would it seem so, since the very article that you link says "BioProtection Systems Corporation (BPS), now a wholly owned subsidiary of NewLink Genetics Inc., has performed at or above expectations thus far." Outside critics don't get to retroactively cancel a contract signed five years ago because progress under the contract doesn't meet their post-hoc expectations.
Seems like they sat on it as long as possible, then sublicensed to Merck.
Funny, the very article that you linked to says that "[l]ast week, we announced the beginning of clinical trials of the vaccine in Canada." Do you have any direct knowledge of the typical work and time involved in setting up clinical safety trials? I doubt it. Note the following:
Preclinical Testing: A pharmaceutical company conducts certain studies before the future drug is ever given to a human being. Laboratory and animal studies must be done to demonstrate the biological activity of the drug against the targeted disease. The drug must also be evaluated for safety. These tests take on the average 3 1/2 years.
At this point though, who cares about the lousy $50M,
TFA.
[T]hey should just get on with producing the fricking stuff while testing in parallel.
Because mass producing an experimental drug that has not been shown to be safe, much less effective, in vivo goes against more than a half century's worth of applied medical knowledge and ethics, notwithstanding the losses you would suffer if you stockpiled a drug that failed clinical trials? But hey, you can assume safety since nobody has been hurt yet, right?